Metabolic Response of Prostate Cancer to Nicotinamide Phophoribosyltransferase Inhibition in a Hyperpolarized MR/PET Compatible Bioreactor

BACKGROUND: Metabolic shifts in disease are of great interest for the development of novel therapeutics. In cancer treatment, these therapies exploit the metabolic phenotype associated with oncogenesis and cancer progression. One recent strategy involves the depletion of the cofactors needed to main...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Prostate
Egile Nagusiak: Keshari, Kayvan R., Wilson, David M., Van Criekinge, Mark, Sriram, Renuka, Koelsch, Bertram L., Wang, Zhen J., VanBrocklin, Henry F., Peehl, Donna M., O’Brien, Tom, Sampath, Deepak, Carano, Richard A. D., Kurhanewicz, John
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4537380/
https://ncbi.nlm.nih.gov/pubmed/26177608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23036
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak